Kymera Therapeutics, Inc.
Related Filers (48)
- Mainolfi Nello (29)
- BIOTECHNOLOGY VALUE FUND L P (21)
- Jacobs Bruce N. (19)
- BVF PARTNERS L P/IL (16)
- BVF GP HOLDINGS LLC (16)
- BVF Partners OS Ltd. (16)
- BVF I GP LLC (16)
- BIOTECHNOLOGY VALUE FUND II LP (16)
- LAMPERT MARK N (16)
- BVF INC/IL (16)
- BVF II GP LLC (16)
- Biotechnology Value Trading Fund OS LP (16)
- Booth Bruce (13)
- Atlas Venture Fund X, L.P. (12)
- Gollob Jared (12)
- Ridloff Elena (9)
- Atlas Venture Associates X, LLC (8)
- ATLAS VENTURE ASSOCIATES X, L.P. (8)
- Albers Jeffrey W. (8)
- Atlas Venture Associates Opportunity I, LLC (6)
- Atlas Venture Opportunity Fund I, L.P. (6)
- Atlas Venture Associates Opportunity I, L.P. (6)
- Hrustanovic Gorjan (6)
- Horobin Joanna (6)
- Esposito Pamela (6)
- Redmile Group, LLC (5)
- Chesworth Richard (5)
- PRICE T ROWE ASSOCIATES INC /MD/ (5)
- Hall Steven Edward (4)
- Nicholson Donald William (4)
- Chiniara Ellen (4)
- Caughey Elaine (4)
- Morgan Leigh (4)
- Sandor Victor (4)
- MARAGANORE JOHN (4)
- BlackRock Inc. (3)
- WELLINGTON MANAGEMENT GROUP LLP (3)
- VANGUARD GROUP INC (3)
- Hedin Andrew (2)
- Green Jeremy (2)
- Alexandria Venture Investments, LLC (2)
- Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (2)
- FMR LLC (2)
- STATE STREET CORP (2)
- Avoro Capital Advisors LLC (2)
- BAKER BROS. ADVISORS LP (2)
- Chadwick Jeremy G (2)
- VERTEX PHARMACEUTICALS INC / MA (2)
- Show More ...
Financials (13)
10-Q
Thursday, 11/2/2023
Quarterly Report for period ending 2023-09-30
10-Q
Thursday, 8/3/2023
Quarterly Report for period ending 2023-06-30
10-Q
Thursday, 5/4/2023
Quarterly Report for period ending 2023-03-31
10-K
Thursday, 2/23/2023
Annual Report for period ending 2022-12-31
10-Q
Thursday, 11/3/2022
Quarterly Report for period ending 2022-09-30
10-Q
Tuesday, 8/9/2022
Quarterly Report for period ending 2022-06-30
10-Q
Tuesday, 5/3/2022
Quarterly Report for period ending 2022-03-31
10-K
Thursday, 2/24/2022
Annual Report for period ending 2021-12-31
10-Q
Wednesday, 11/10/2021
Quarterly Report for period ending 2021-09-30
10-Q
Friday, 8/6/2021
Quarterly Report for period ending 2021-06-30
10-Q
Thursday, 5/6/2021
Quarterly Report for period ending 2021-03-31
10-K
Thursday, 3/11/2021
Annual Report for period ending 2020-12-31
10-Q
Thursday, 11/5/2020
Quarterly Report for period ending 2020-09-30
News (42)
8-K
Friday, 1/5/2024
Current report filing
8-K
Thursday, 1/4/2024
Current report filing
8-K
Thursday, 1/4/2024
Current report filing
8-K
Thursday, 11/2/2023
Current report filing
8-K
Thursday, 11/2/2023
Current report filing
8-K
Thursday, 8/3/2023
Current report filing
8-K
Friday, 6/16/2023
Current report filing
8-K
Monday, 5/22/2023
Current report filing
8-K
Thursday, 5/4/2023
Current report filing
8-K
Friday, 3/10/2023
Current report filing
8-K
Monday, 2/27/2023
Current report filing
8-K
Thursday, 2/23/2023
Current report filing
8-K
Tuesday, 1/10/2023
Current report filing
8-K
Wednesday, 12/14/2022
Current report filing
8-K
Wednesday, 12/14/2022
Current report filing
8-K
Thursday, 11/3/2022
Current report filing
8-K
Thursday, 10/13/2022
Current report filing
8-K
Friday, 8/19/2022
Current report filing
8-K
Tuesday, 8/9/2022
Current report filing
8-K
Friday, 7/8/2022
Current report filing
8-K
Thursday, 6/16/2022
Current report filing
8-K
Tuesday, 5/3/2022
Current report filing
8-K
Monday, 4/11/2022
Current report filing
8-K
Thursday, 2/24/2022
Current report filing
8-K
Tuesday, 1/18/2022
Current report filing
8-K
Monday, 12/27/2021
Current report filing
8-K
Thursday, 12/16/2021
Current report filing
8-K
Wednesday, 11/10/2021
Current report filing
8-K
Wednesday, 10/27/2021
Current report filing
8-K
Thursday, 9/16/2021
Current report filing
8-K
Friday, 8/6/2021
Current report filing
8-K
Monday, 6/28/2021
Current report filing
8-K
Thursday, 6/17/2021
Current report filing
8-K
Thursday, 5/6/2021
Current report filing
8-K
Tuesday, 3/16/2021
Current report filing
8-K
Thursday, 3/11/2021
Current report filing
8-K
Tuesday, 3/2/2021
Current report filing
8-K
Tuesday, 1/12/2021
Current report filing
8-K
Thursday, 11/5/2020
Current report filing
8-K
Wednesday, 9/9/2020
Current report filing
8-K
Tuesday, 9/1/2020
Current report filing
8-K
Tuesday, 8/25/2020
Current report filing
Other (17)
144
Friday, 2/9/2024
Filing for proposed sale of securities under Rule 144
144
Tuesday, 1/23/2024
Filing for proposed sale of securities under Rule 144
144
Thursday, 1/4/2024
Filing for proposed sale of securities under Rule 144
ARS
Thursday, 4/27/2023
Annual report to security holders
EFFECT
Wednesday, 6/30/2021
Notice of Effectiveness
CORRESP
Monday, 6/28/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 6/28/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
SEC STAFF LETTER
Thursday, 3/11/2021
None
SEC STAFF LETTER
Wednesday, 2/10/2021
None
CERT
Thursday, 8/20/2020
Certification by an exchange approving securities for listing
EFFECT
Thursday, 8/20/2020
Notice of Effectiveness
8-A12B
Tuesday, 8/18/2020
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Tuesday, 8/18/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 8/18/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Thursday, 8/13/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 8/5/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 7/31/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Ownership (200)
SC 13G/A
Wednesday, 2/14/2024
Avoro Capital Advisors LLC: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
VANGUARD GROUP INC: Major Shareholders
SC 13G/A
Monday, 2/12/2024
PRICE T ROWE ASSOCIATES INC /MD/: Major Shareholders
SC 13G/A
Monday, 2/12/2024
PRICE T ROWE ASSOCIATES INC /MD/: Major Shareholders
4
Friday, 2/9/2024
Gollob Jared: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/9/2024
Atlas Venture Fund X, L.P.: Major Shareholders
SC 13G/A
Thursday, 2/8/2024
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13G/A
Monday, 1/29/2024
BlackRock Inc.: Major Shareholders
SC 13G/A
Tuesday, 1/23/2024
STATE STREET CORP: Major Shareholders
4
Tuesday, 1/23/2024
Albers Jeffrey W.: Statement of changes in beneficial ownership of securities
SC 13G/A
Wednesday, 1/10/2024
BAKER BROS. ADVISORS LP: Major Shareholders
SC 13D/A
Tuesday, 1/9/2024
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
4
Tuesday, 1/9/2024
BIOTECHNOLOGY VALUE FUND L P: Statement of changes in beneficial ownership of securities
4
Friday, 1/5/2024
Chiniara Ellen: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/2/2024
Mainolfi Nello: Statement of changes in beneficial ownership of securities
4
Monday, 11/6/2023
BIOTECHNOLOGY VALUE FUND L P: Statement of changes in beneficial ownership of securities
4
Monday, 11/6/2023
Mainolfi Nello: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/8/2023
Mainolfi Nello: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Morgan Leigh: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Sandor Victor: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Horobin Joanna: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Esposito Pamela: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
BIOTECHNOLOGY VALUE FUND L P: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Booth Bruce: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Ridloff Elena: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
MARAGANORE JOHN: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Albers Jeffrey W.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/20/2023
Hrustanovic Gorjan: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 6/5/2023
VERTEX PHARMACEUTICALS INC / MA: Major Shareholders
4
Friday, 6/2/2023
Jacobs Bruce N.: Statement of changes in beneficial ownership of securities
3
Monday, 5/22/2023
Chadwick Jeremy G: Initial statement of beneficial ownership of securities
4
Monday, 5/22/2023
Chadwick Jeremy G: Statement of changes in beneficial ownership of securities
4
Friday, 3/3/2023
Mainolfi Nello: Statement of changes in beneficial ownership of securities
4
Friday, 3/3/2023
Jacobs Bruce N.: Statement of changes in beneficial ownership of securities
4
Friday, 3/3/2023
Gollob Jared: Statement of changes in beneficial ownership of securities
4
Friday, 3/3/2023
Caughey Elaine: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
PRICE T ROWE ASSOCIATES INC /MD/: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Redmile Group, LLC: Major Shareholders
SC 13G
Tuesday, 2/14/2023
BAKER BROS. ADVISORS LP: Major Shareholders
SC 13G
Tuesday, 2/14/2023
Avoro Capital Advisors LLC: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Atlas Venture Fund X, L.P.: Major Shareholders
SC 13G/A
Thursday, 2/9/2023
VANGUARD GROUP INC: Major Shareholders
SC 13G
Wednesday, 2/8/2023
STATE STREET CORP: Major Shareholders
SC 13G/A
Monday, 2/6/2023
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13G/A
Wednesday, 2/1/2023
BlackRock Inc.: Major Shareholders
4
Friday, 1/13/2023
Atlas Venture Fund X, L.P.: Statement of changes in beneficial ownership of securities
4
Friday, 1/13/2023
BIOTECHNOLOGY VALUE FUND L P: Statement of changes in beneficial ownership of securities
4
Friday, 1/13/2023
Booth Bruce: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/4/2023
Chiniara Ellen: Statement of changes in beneficial ownership of securities
3
Wednesday, 1/4/2023
Chiniara Ellen: Initial statement of beneficial ownership of securities
4
Friday, 12/16/2022
Booth Bruce: Statement of changes in beneficial ownership of securities
4
Friday, 12/16/2022
Atlas Venture Fund X, L.P.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/8/2022
Mainolfi Nello: Statement of changes in beneficial ownership of securities
4
Friday, 11/4/2022
Booth Bruce: Statement of changes in beneficial ownership of securities
4
Friday, 11/4/2022
Atlas Venture Fund X, L.P.: Statement of changes in beneficial ownership of securities
3
Thursday, 11/3/2022
Sandor Victor: Initial statement of beneficial ownership of securities
4
Thursday, 11/3/2022
Sandor Victor: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
Booth Bruce: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/1/2022
Atlas Venture Fund X, L.P.: Statement of changes in beneficial ownership of securities
4
Monday, 10/24/2022
Jacobs Bruce N.: Statement of changes in beneficial ownership of securities
4
Monday, 10/17/2022
Jacobs Bruce N.: Statement of changes in beneficial ownership of securities
4
Monday, 10/17/2022
Mainolfi Nello: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 8/23/2022
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
4
Tuesday, 8/23/2022
BIOTECHNOLOGY VALUE FUND L P: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 7/11/2022
PRICE T ROWE ASSOCIATES INC /MD/: Major Shareholders
3
Friday, 7/8/2022
Morgan Leigh: Initial statement of beneficial ownership of securities
4
Friday, 7/8/2022
Morgan Leigh: Statement of changes in beneficial ownership of securities
4
Friday, 7/1/2022
Ridloff Elena: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
BIOTECHNOLOGY VALUE FUND L P: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Booth Bruce: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Hrustanovic Gorjan: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Esposito Pamela: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Albers Jeffrey W.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Ridloff Elena: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Horobin Joanna: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Nicholson Donald William: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 6/1/2022
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
4
Tuesday, 5/31/2022
BIOTECHNOLOGY VALUE FUND L P: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/24/2022
BIOTECHNOLOGY VALUE FUND L P: Statement of changes in beneficial ownership of securities
4
Monday, 5/9/2022
BIOTECHNOLOGY VALUE FUND L P: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/4/2022
Gollob Jared: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/3/2022
Mainolfi Nello: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/3/2022
Jacobs Bruce N.: Statement of changes in beneficial ownership of securities
4/A
Friday, 4/15/2022
Ridloff Elena: Statement of changes in beneficial ownership of securities
4/A
Friday, 4/15/2022
Ridloff Elena: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2022
Caughey Elaine: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2022
Jacobs Bruce N.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2022
Mainolfi Nello: Statement of changes in beneficial ownership of securities
4
Thursday, 3/3/2022
Gollob Jared: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 2/14/2022
PRICE T ROWE ASSOCIATES INC /MD/: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Redmile Group, LLC: Major Shareholders
SC 13G/A
Friday, 2/11/2022
Atlas Venture Fund X, L.P.: Major Shareholders
SC 13G
Thursday, 2/10/2022
VANGUARD GROUP INC: Major Shareholders
SC 13G/A
Wednesday, 2/9/2022
FMR LLC: Major Shareholders
SC 13G
Friday, 2/4/2022
WELLINGTON MANAGEMENT GROUP LLP: Major Shareholders
SC 13G
Friday, 2/4/2022
BlackRock Inc.: Major Shareholders
SC 13D/A
Monday, 1/31/2022
BIOTECHNOLOGY VALUE FUND L P: Major Shareholders
4
Monday, 1/31/2022
BIOTECHNOLOGY VALUE FUND L P: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/26/2022
BIOTECHNOLOGY VALUE FUND L P: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/19/2022
MARAGANORE JOHN: Statement of changes in beneficial ownership of securities
Prospectus (19)
424B5
Friday, 1/5/2024
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 1/4/2024
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Thursday, 2/23/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B3
Tuesday, 9/6/2022
Prospectus filed pursuant to Rule 424(b)(3)
S-8
Thursday, 2/24/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-3ASR
Friday, 10/1/2021
Automatic shelf registration statement of securities of well-known seasoned issuers
424B4
Friday, 7/2/2021
Prospectus filed pursuant to Rule 424(b)(4)
S-1MEF
Wednesday, 6/30/2021
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
S-1
Monday, 6/28/2021
General form of registration statement for all companies including face-amount certificate companies
DRS
Wednesday, 3/17/2021
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
S-8
Thursday, 3/11/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8
Friday, 8/21/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Friday, 8/21/2020
Prospectus filed pursuant to Rule 424(b)(4)
S-1MEF
Thursday, 8/20/2020
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
S-1/A
Monday, 8/17/2020
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Thursday, 8/13/2020
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Wednesday, 8/5/2020
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 7/31/2020
General form of registration statement for all companies including face-amount certificate companies
DRS
Monday, 6/22/2020
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (6)
DEF 14A
Thursday, 4/27/2023
Definitive proxy statements
DEFA14A
Thursday, 4/27/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Friday, 4/29/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Friday, 4/29/2022
Definitive proxy statements
DEF 14A
Friday, 4/30/2021
Definitive proxy statements
DEFA14A
Friday, 4/30/2021
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.